SCH
532706
|
 | FDA-Approved Treatments | |
Protease
Inhibitors | ||
 | Agenerase (amprenavir) | |
 | Aptivus (tipranavir) | |
 | Crixivan (indinavir) | |
 | Invirase (saquinavir hard gel) | |
 | Kaletra (lopinavir/ritonavir) | |
 | Lexiva (fosamprenavir) | |
 | Norvir (ritonavir) | |
 | Prezista (darunavir) | |
 | Reyataz (atazanavir) | |
 | Viracept (nelfinavir) | |
Nucleoside
/ Nucleotide Reverse Transcriptase Inhibitors | ||
 | Combivir (zidovudine/lamivudine) | |
 | Epivir (lamivudine; 3TC) | |
 | Emtriva (emtricitabine; FTC) | |
 | Epzicom (abacavir + lamivudine) | |
 | Retrovir (zidovudine; AZT) | |
 | Trizivir (abacavir + zidovudine +lamivudine) | |
 | Truvada (tenofovir / emtricitabine) | |
 | Videx (didanosine; ddI) | |
 | Viread (tenofovir) | |
 | Zerit (stavudine; d4T) | |
 | Ziagen (abacavir) | |
non
Nucleoside Reverse Transcriptase Inhibitors | ||
 | Rescriptor (delavirdine) | |
 | Sustiva (efavirenz) | |
 | Viramune (nevirapine) | |
Entry
Inhibitors (including Fusion Inhibitors) | ||
 | Fuzeon (enfuvirtide, T-20) | |
 | Selzentry ( maraviroc) | |
Fixed-dose
Combinations | ||
 | Atripla (efavirenz + emtricitabine + tenofovir) | |
| Combivir (zidovudine + lamivudine) | |
| Trizivir (abacavir + zidovudine + lamivudine) | |
| Truvada (tenofovir + emtricitabine) | |